A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs

In diabetic patients, treatment with insulin and pramlintide (an amylin analogue) is more effective than treatment with insulin only. But because mixtures of insulin and pramlintide are unstable and have to be injected separately, amylin analogues are only used by 1.5% of diabetics needing rapid-act...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Biomed Eng
Main Authors: Maikawa, Caitlin L., Smith, Anton A. A., Zou, Lei, Roth, Gillie A., Gale, Emily C., Stapleton, Lyndsay M., Baker, Sam W., Mann, Joseph L., Yu, Anthony C., Correa, Santiago, Grosskopf, Abigail K., Liong, Celine S., Meis, Catherine M., Chan, Doreen, Troxell, Megan, Maahs, David M., Buckingham, Bruce A., Webber, Matthew J., Appel, Eric A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274092/
https://ncbi.nlm.nih.gov/pubmed/32393892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41551-020-0555-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados